3QT-33962-12670
3 vaccinations
5 coded responses
27 check-ins
5 free-text entries
5 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 136 / NY
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Registered in v-safe
-
2021-01-18
Dose 1 — Pfizer-BioNTech
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-02-01
-
2021-02-08
Dose 2 — Pfizer-BioNTech
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-11
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-15
Health check-in — day 7, dose 2Feeling: Good · Site: Pain, Redness, Swelling · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-22
Survey response — day 14, dose 2MedDRA: Deep vein thrombosis, Rash — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: I developed a DVT in my left arm, the arm I had the vaccine in. My blood thinner was changed from Xarelto to Lovenox. I also have had a rash on my back, stomach, arms and legs. Benadryl has helped and that is much better the last couple of days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-05-10
-
2021-08-14
Survey response — 6 months, dose 2MedDRA: Myelodysplastic syndrome unclassifiable — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with MDS-U (13q)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-14
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-17
- 2021-08-21
-
2021-08-30
Dose 3 — Pfizer-BioNTech
-
2021-09-08
Call successfulParticipant prefers to complete VAERS report online
-
2021-09-08
Call successfulParticipant prefers to complete VAERS report online
-
2021-09-30
Survey response — day 28, dose 3MedDRA: Acute kidney injury, Acute respiratory failure, Adrenal insufficiency, Hospitalisation, Inflammation, Shock — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: The day after 3rd vaccineacute respiratory failure, AKI, and shock. No organisms were identified. The conclusion was a robust inflammatory response to the vaccination which triggered adrenal insufficiency. I spent 6 days in hospital 8/31-9/6MedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-10-04
-
2021-10-04
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2021-10-11
- 2021-12-03
-
2022-02-28
Survey response — 6 months, dose 3MedDRA: Localised infection, Pre-existing disease, Staphylococcal infection, Thrombocytopenia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Thrombocytopenia requiring Promacta/Elthrombopag MRSA of toeMedDRA releases: 2024-11 · check-in free text available
-
2022-02-28
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-03-01
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-08-30
Survey response — 12 months, dose 3MedDRA: Anaemia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening anemia requiring blood transfusionsMedDRA releases: 2024-11 · check-in free text available
-
2022-08-30
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Pfizer-BioNTech | |
| 2 | 2021-02-08 | Pfizer-BioNTech | |
| 3 | 2021-08-30 | Pfizer-BioNTech | No |
Call center
5 call center cases
4 successful · 1 unsuccessful
VAERS report filed, before or during a call: 2
1 wait over 3 months for a first call
Free text
Release 4 — day 14, dose 2
Symptoms: I developed a DVT in my left arm, the arm I had the vaccine in. My blood thinner was changed from Xarelto to Lovenox. I also have had a rash on my back, stomach, arms and legs. Benadryl has helped and that is much better the last couple of days.
Release 9 — 6 months, dose 2
Symptoms: Diagnosed with MDS-U (13q)
Release 9 — day 28, dose 3
Symptoms: The day after 3rd vaccineacute respiratory failure, AKI, and shock. No organisms were identified. The conclusion was a robust inflammatory response to the vaccination which triggered adrenal insufficiency. I spent 6 days in hospital 8/31-9/6
Release 11 — 6 months, dose 3
Symptoms: Thrombocytopenia requiring Promacta/Elthrombopag MRSA of toe
Release 12 — 12 months, dose 3
Symptoms: Worsening anemia requiring blood transfusions
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Acute kidney injury | · | · | ✓ |
| SD | Acute respiratory failure | · | · | ✓ |
| SD | Adrenal insufficiency | · | · | ✓ |
| SD | Anaemia | · | · | ✓ |
| SD | Deep vein thrombosis | ✓ | ✓ | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Localised infection | · | · | ✓ |
| SD | Myelodysplastic syndrome unclassifiable | ✓ | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Shock | · | · | ✓ |
| SD | Staphylococcal infection | · | · | ✓ |
| SD | Thrombocytopenia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release